| Dr Maura Shea, | |
|
567 N 5th St, Terre Haute, IN 47809-1903 | |
| (812) 237-9613 | |
| Not Available |
| Full Name | Dr Maura Shea |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
| Location | 567 N 5th St, Terre Haute, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578956736 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | 36002903A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maura Shea, 567 N 5th St, Terre Haute, IN 47809-1903 Ph: () - | Dr Maura Shea, 567 N 5th St, Terre Haute, IN 47809-1903 Ph: (812) 237-9613 |
News Archive
Heraeus Kulzer, LLC, the worldwide leader in dental esthetics, announced today that its iBOND Self Etch bonding agent received the maximum possible "5-plus" rating from THE DENTAL ADVISOR. The iBOND Self Etch bottle kit was evaluated by 26 consultants in 648 uses and received a very impressive 96% clinical rating.
Judith Tsui, a UW Medicine clinician specializing in addiction treatment, was seeing more and more patients she was treating for opioid-use disorder also using methamphetamines, a powerful, highly addictive stimulant that affects the central nervous system.
Vitamin D-deficient individuals are twice as likely to be diagnosed with schizophrenia as people who have sufficient levels of the vitamin, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
ViewRay, Inc., a privately held medical device company, has earned a NorTech Innovation Award for its advancements in radiation therapy technology for the treatment of cancer. ViewRay was honored for its unique combination of medical imaging and radiotherapy, which is designed to improve the effectiveness of cancer treatments. Radiation therapy is used to treat nearly two-thirds of today's cancer patients.
Novartis today announced data from the Phase III COMBI-d study showing a significant survival benefit for patients with BRAF V600E/K mutation-positive metastatic melanoma when treated with the combination of Tafinlar (dabrafenib) and Mekinist (trametinib) compared to Tafinlar monotherapy alone.
› Verified 9 days ago
Chitra Gowda, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7000 | |
Brittney Marie Millspaugh Storms, Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 567 N 5th St, Terre Haute, IN 47809 Phone: 812-237-9613 | |
Mr. Ashley P Matchett, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 4146 S 7th Street, Terre Haute, IN 47802 Phone: 812-242-2332 Fax: 812-242-2772 | |
Pragnaben S Patel, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1606 N 7th St, Terre Haute, IN 47804 Phone: 812-238-7000 Fax: 812-238-7478 | |
Dr. Fred Kelley Lamb, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1019 E Springhill Dr, Terre Haute, IN 47802 Phone: 812-298-9797 Fax: 812-298-0343 | |
Dr. Ofelia Balagtas-balmaseda, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 4812 S 7th St, Terre Haute, IN 47802 Phone: 812-299-7422 Fax: 812-299-1683 |